Download to read offline
Uploaded byfinance28
280 views
boston scientificAR06financials
This document is Boston Scientific's 2006 consolidated financial statements. It includes sections such as management's discussion and analysis of financial condition and results of operations, consolidated statements of operations, balance sheets, cash flows, notes to the financial statements, and other financial data. In 2006, Boston Scientific acquired Guidant Corporation, becoming a major provider in the cardiac rhythm management business with annual sales of over $7.8 billion. However, the acquisition and integration resulted in significant one-time charges, leading to a reported net loss of $3.6 billion for the year. Cash flow from operations remained strong at $1.8 billion.
